ArticleBMC infectious diseases2026
Clinical and molecular characterizations of carbapenem-resistant Klebsiella pneumoniae among children with bloodstream infections in Beijing, China.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) in children pose a significant challenge to global public health and place tremendous pressure on clinical antibiotic treatment. A longitudinal retrospective study was designed to elucidate the clinical features, antibiotic resistance phenotypes, and molecular characteristics of CRKP isolated from bloodstream infections in children.
methodsCRKP strains were collected from blood cultures over an eight-year period (2018-2025) at a tertiary children's hospital in Beijing, China. Antimicrobial susceptibility testing and whole-genome sequencing (WGS) were performed to examine the resistance patterns and genetic diversity.
resultsCRKP bloodstream infections exhibited a distinct age-related pattern, with the highest incidence observed in infants younger than 3 months. Among the 91 isolates studied, none showed resistance to tigecycline or polymyxin B. The predominant carbapenemase genes identified were bla
conclusionPediatric CRKP bloodstream infections, predominantly affect young infants and are mediated primarily by bla
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.